top of page
LOGO NATIONAL RESEARCH CENTERS BLANCO.png
pancreatic-cancer-awareness-month-2022-11-07-22-06-50-utc_edited.jpg

Lighting the Path to Lupus Wellness

Welcome to D&H National Research Centers, where we invite you to be a part of groundbreaking research that aims to improve the lives of individuals living with lupus and get up $1500 compensation.

Lupus, or systemic lupus erythematosus (SLE), is an autoimmune disease in which the immune system mistakenly attacks healthy tissues and organs. This can lead to a wide range of symptoms and complications, including joint pain, skin rashes, fatigue, and damage to vital organs. Lupus is a challenging condition to manage, and we are committed to finding better treatments and ultimately, a cure.

Diseño sin título (2)_edited_edited.png


At D&H National Research Centers, we are at the forefront of lupus research and conducting a cutting-edge medical trials to advance the treatment options for lupus patients.

If you have a diagnosis of  SLE (Systemic lupus erythematosus) you are able to participate in our trial and receive up $1500 in compensation for participating in the study.

Our trial is designed to:

1. Evaluate the effectiveness of new lupus treatments.


2. Understand the underlying causes and triggers of lupus.


3. Improve the quality of life for individuals with lupus.

D&H National Research Centers is currently conducting a study on Lupus. As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.

Inclusion Criteria:

 

If you want to participate in this study, you must meet the following criteria:

  • Male or female subjects aged from 18 to 75 years old (both inclusive).

  • Diagnosis of SLE (Systemic lupus erythematosus )made at least 6 months prior to Screening.

  • Musculoskeletal or mucocutaneous manifestations (i.e., myositis, arthritis, rash, alopecia, mucosal ulcers).

  • Currently treated with one or more of the following SLE background medications:
    • Antimalarials, Mycophenolate mofetil, Azathioprine, Methotrexate, OCS or Belimumab.

Exclusion Criteria:

 

You are not eligible for participation in this study if:

 

  • Pregnant or lactating women.

  • Active severe SLE-driven renal disease.

  • Severe forms of vasculitis requiring systemic immunosuppressive treatment.

  • History or presence of severe respiratory disease or pulmonary fibrosis.

  • Myocardial infarction, unstable angina pectoris, stroke, transient ischemic attack, vascular thrombosis, decompensated heart failure requiring hospitalization, or heart failure within 6 months prior to Screening.

  • History or presence of severe respiratory disease or pulmonary fibrosis, Tuberculosis, Hepatitis A, B, C, HIV.

  • History or presence of bone marrow or solid organ transplantation.

Join the study

D&H National Research Centers is a leading medical trial center located in Florida. 

If you are interested in joining our lupus medical trial or have questions about the study, please don't hesitate to reach out to us. We are here to provide you with all the information and support you need, please fill the form or contact us by phone: (786) 375-6210

Lighting the Path to Lupus Wellness

bottom of page